超低剂量四重组合治疗高血压的成本效益
Emily R Atkins1, Alexander Chye2, Thomas Lung2,3
1The George Institute for Global Health, UNSW, Sydney, New South Wales, Australia eatkins@georgeinstitute.org.au.
Heart (British Cardiac Society)
|August 8, 2023
概括
四药丸在降低血压方面表现出类似的短期成本效益. 长期经济建模表明,四药疗法可能是高血压管理的成本效益.
科学领域:
- 心血管医学 心血管医学
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
背景情况:
- 高血压管理需要有效和负担得起的治疗策略.
- 固定剂量组合疗法可以改善坚持和结果.
- 评估新型抗高血压疗法的经济价值至关重要.
研究的目的:
- 为了评估四药丸 (伊尔贝沙坦,阿姆洛地平,伊达帕米德,比索普罗罗罗尔) 与伊尔贝沙坦单一治疗的成本效益和成本效益.
- 为了比较短期的血压降低成本和长期的质量调整寿命年 (QALY) 收益.
主要方法:
- 在试验内和模拟经济评估中,使用了高血压试验的四次超低剂量治疗的数据进行了试验.
- 分析包括药物和卫生服务的使用,计算系统性血压 (BP) 降低的增量成本效益比率 (ICER) 和QALYs.
主要成果:
- 试验内部分析显示,四片药和单疗法之间的每毫米血压下降成本在3个月内没有显著差异.
- 建模的终身分析预计,通过四片药治疗获得的平均增量成本为A265美元和0.02个QALY.
- 在基准案例 (ICER $A14,006每QALY) 中,四药丸具有成本效益,对药物成本有敏感性.
结论:
- 四种药丸疗法提供了与单一疗法相比的成本效益,用于短期降低血压.
- 长期经济预测表明,四药疗法可能是高血压的成本有效策略.
- 这些发现支持超低剂量联合治疗在高血压管理中的潜在价值.
相关概念视频
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
14
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
14
01:30Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
01:26Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:27Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11